Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments (2014)
- Authors:
- USP affiliated authors: HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; TONE, LUIZ GONZAGA - FMRP ; ANNICHINI, MARIA SOL BRASSESCO - FFCLRP
- Unidades: FFCLRP; FMRP
- DOI: 10.4236/jct.2014.54037
- Subjects: OSTEOSSARCOMA; NEOPLASIAS ÓSSEAS; ANTINEOPLÁSICOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Cancer Therapy
- ISSN: 2151-1934
- Volume/Número/Paginação/Ano: v. 5, n. 4, p. 307-314, 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MONTALDI, Ana Paula et al. Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments. Journal of Cancer Therapy, v. 5, n. 4, p. 307-314, 2014Tradução . . Disponível em: https://doi.org/10.4236/jct.2014.54037. Acesso em: 19 abr. 2024. -
APA
Montaldi, A. P., Pezuk, J. A., Sakamoto-Hojo, E. T., Tone, L. G., & Brassesco, M. S. (2014). Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments. Journal of Cancer Therapy, 5( 4), 307-314. doi:10.4236/jct.2014.54037 -
NLM
Montaldi AP, Pezuk JA, Sakamoto-Hojo ET, Tone LG, Brassesco MS. Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments [Internet]. Journal of Cancer Therapy. 2014 ; 5( 4): 307-314.[citado 2024 abr. 19 ] Available from: https://doi.org/10.4236/jct.2014.54037 -
Vancouver
Montaldi AP, Pezuk JA, Sakamoto-Hojo ET, Tone LG, Brassesco MS. Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments [Internet]. Journal of Cancer Therapy. 2014 ; 5( 4): 307-314.[citado 2024 abr. 19 ] Available from: https://doi.org/10.4236/jct.2014.54037 - Interplay between the RNA binding‐protein Musashi and developmental signaling pathways
- Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia [Editorial]: do we have enough information to warrant this association?
- Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in all (acute lymphoblastic leukemia) cured patients
- Análise de fusões TEL/AML1 e alterações no cromossomo 12 em pacientes que apresentaram leucemia linfóide aguda na infância para a avaliação dos efeitos tardios da terapia anti-cancer
- Avaliação dos efeitos tardios da terapia anticâncer por meio das alterações no gene MLL detectadas por fiber-FISH em pacientes que apresentaram leucemia linfóide aguda na infância
- Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients
- Analysis of ETV6/Runx fusions for evaluating the late effects of cancer thereapy in all (acute lymphoblistic leukemia)cured patients
- Genetic late effects of cancer therapy, as detected by IGH/MYC fusion genes, in lymphoma pediatric patients
- Analysis of TEL/AML1 fusions and alterations on chromossome 12 to evaluate the late effects of cancer therapy in leukemia (ALL) cured patients
- Avaliação dos efeitos genéticos tardios da terapia antcâncer em pacientes pediátricos que apresentaram Tumor de Wilms na infância
Informações sobre o DOI: 10.4236/jct.2014.54037 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
